Your browser doesn't support javascript.
loading
Patients' subjective assessment as a decisive predictor of malignancy in pelvic masses: results of a multicentric, prospective pelvic mass study.
Koch, Elisa; Torsten, Uwe; Mecke, Herbert; Richter, Rolf; Hellmeyer, Lars; Nohe, Gerhard; Müller, Bodo; Boeneß-Zaloum, Janine; Ames, Kerstin; Chen, Frank; Beteta, Carmen; Hasenbein, Kati; Pirmorady, Adak; Zimmermann, Mathias; Dimitrova, Desislava; Tauber, Rudolf; Sehouli, Jalid; Knieper, Catherine Linn; Ioana Braicu, Elena.
Afiliação
  • Koch E; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Torsten U; Department for Gynecology, Vivantes Klinikum Neukölln, Berlin, Germany.
  • Mecke H; Department for Obstetrics and Gynecology, AVK Vivantes, Berlin, Germany.
  • Richter R; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Hellmeyer L; Department for Obstetrics and Gynecology, Vivantes Klinikum Friedrichshain, Berlin, Germany.
  • Nohe G; Department for Obstetrics and Gynecology, Vivantes Klinikum am Urban, Berlin, Germany.
  • Müller B; Department for Gynecology, Vivantes Klinikum Kaulsdorf, Berlin, Germany.
  • Boeneß-Zaloum J; Department for Obstetrics and Gynecology, Vivantes Klinikum Friedrichshain, Berlin, Germany.
  • Ames K; Department for Gynecology, Vivantes Klinikum Neukölln, Berlin, Germany.
  • Chen F; Department for Obstetrics and Gynecology, AVK Vivantes, Berlin, Germany.
  • Beteta C; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Hasenbein K; Department for Gynecology, Vivantes Humboldt-Klinikum, Berlin, Germany.
  • Pirmorady A; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Zimmermann M; Central Institute of Laboratory Medicine, DRK Kliniken Berlin, Berlin, Germany.
  • Dimitrova D; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Tauber R; Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Sehouli J; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Knieper CL; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Ioana Braicu E; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
J Psychosom Obstet Gynaecol ; 43(3): 273-278, 2022 09.
Article em En | MEDLINE | ID: mdl-33252280
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article